Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKB103 in Advanced HER2-negative Breast Cancer
NCT07774624Phase 2Not yet recruiting
- Sponsor
- Kelun-Biotech
- Start
- Aug 2026
- Primary completion
- Dec 2029
01
Overview
A Phase 2 trial of SKB103 in breast cancer, sponsored by Kelun-Biotech. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
SKB103
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07774624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07774624.